Similar Articles

Nationwide prescription big data: An evaluation of injectable, oral, and monoclonal antibody disease-modifying therapies in multiple sclerosis

Esra Taşkıran, Bilgin Öztürk, Naim Ata, Şuayip Birinci

DOI: 10.55697/tnd.2026.622

Issue: 2026, Volume 32 - Issue 1
1276 817

Recorded diagnosis-based incidence and point prevalence of multiple sclerosis in Azerbaijan between 2013 and 2022: Estimates from a national referral center registry

Rahim Aliyev, Ayten Mammadbayli, Rana Shiraliyeva

DOI: 10.55697/tnd.2026.749

Issue: 2026, Volume 32 - Issue 3
0 13